BAUN 2022: High-risk nmCRPC - Expert guidance on the management and treatment of patients on androgen receptor inhibitors
Description
In this Bayer sponsored symposium, recorded at the British Association of Urological Nurses (BAUN) 2022 annual conference, Ms Louisa Fleure from Guy’s and St Thomas’ NHS Foundation Trust leads a talk about the real-world treatment of nmCRPC, highlighting what is important to the patient and how treatment can be optimised from a multidisciplinary perspective.
Joining her on the expert panel, Dr Vincent Khoo from The Royal Marsden NHS Foundation Trust explores the current treatment options for patients with nmCRPC and provides his expert opinion on identifying and treating eligible patients.
The webinar concludes with an interactive Q&A chaired by Ms Louisa Fleure.
Watch the highlights NOW below.
This webinar was organised and funded by Bayer plc.
Abbreviations: ARI, androgen receptor inhibitor; nmCRPC, non-metastatic castration-resistant prostate cancer.
PP-NUB-GB-1314 | February 2024